Aurora Cannabis (TSE:ACB) Reaches New 1-Year Low at $2.33

Aurora Cannabis Inc. (TSE:ACBGet Rating)’s stock price hit a new 52-week low during trading on Friday . The company traded as low as C$2.33 and last traded at C$2.34, with a volume of 2603111 shares. The stock had previously closed at C$3.47.

A number of brokerages have recently commented on ACB. MKM Partners reiterated a “hold” rating and set a C$3.00 price target (down previously from C$6.50) on shares of Aurora Cannabis in a report on Friday, May 13th. ATB Capital dropped their target price on shares of Aurora Cannabis from C$5.00 to C$4.00 and set an “underperform” rating on the stock in a report on Tuesday, May 10th. Cowen dropped their target price on shares of Aurora Cannabis from C$7.00 to C$4.00 in a report on Monday, May 16th. Piper Sandler dropped their target price on shares of Aurora Cannabis from C$7.00 to C$4.00 and set a “hold” rating on the stock in a report on Friday, May 13th. Finally, CIBC dropped their target price on shares of Aurora Cannabis from C$6.50 to C$3.75 in a report on Monday, May 16th. Two analysts have rated the stock with a sell rating and six have given a hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of C$4.48.

The company has a quick ratio of 3.95, a current ratio of 5.85 and a debt-to-equity ratio of 35.61. The stock has a 50 day simple moving average of C$4.17 and a 200 day simple moving average of C$5.76. The stock has a market cap of C$496.69 million and a price-to-earnings ratio of -0.38.

Aurora Cannabis Company Profile (TSE:ACB)

Aurora Cannabis Inc produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.

Featured Stories

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.